Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks

Status unconfirmed · Phase 4

Conditions studied: Influenza, Influenza, Human, Influenza -Like Illness

In brief

Influenza outbreaks are a prevalent event in nursing homes (NHs). We will study baloxavir compared to oseltamivir when used for influenza prophylaxis when facilities identify an index incident case of influenza. This study will help guide nursing home's decision making and demonstrate the effectiveness of a novel antiviral for preventing influenza outbreaks.

Key facts

Study ID

NCT05012189

Run by

Insight Therapeutics, LLC

People needed

1000

Starts

2021-08-06

Expected to finish

2023-12-01

Last updated by the study team

2023-03-15

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Medicare-certified NHs in any location in the United States with at least 50 long-stay residents 18 years of age or older.

You may not qualify if…

• Hospital-based facilities
• Facilities not submitting MDS data

Where it is running

• Insight Therapeutics, LLC — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.